 It has about 44% of the affinity of progesterone for the progesterone receptor.The medication is described as a relatively weak progestogen, similarly to its analogue dimethisterone.Its total endometrial transformation dosage per 10 to 14 days in women is 200 to 700 mg. Ethisterone has about 20-fold lower potency as a progestogen relative to norethisterone.